Effective October 1, 2024, the Michigan Department of Health and Human (MDHHS) will terminate coverage for several Covid-19 services, under notice 2419-Lab. These Covid-19 policy updates will include the following:

• Medicaid coverage for over the counter Covid-19 home test kits will be discontinued.
• Special reimbursement for Covid-19 laboratory specimen collection will end. Additionally, reimbursement will end for Independent Clinical laboratories collecting a COVID-19 specimen.
• Special reimbursement for vaccine administration by Federally Qualified Health Centers, Rural Health Clinics, Tribal Health Centers and Tribal Federally Qualified Health Centers will end. Covid-19 vaccine administration will revert to the applicable clinic reimbursement policy.
• Medicaid will cover laboratory-performed Covid-19 testing when ordered by an allowable practitioner but must be medically necessary in accordance with Medicaid laboratory policy.
• The Public Readiness and Emergency Preparedness Act continues to allow the ordering of COVID-19 testing by a range of qualified medical professionals through December 31, 2024. In alignment, Medicaid will continue to allow enrolled pharmacists to be reported as the ordering provider for OTC Covid-19 home test kits dispensed by a Medicaid-enrolled pharmacy, and on laboratory performed Covid-19 tests for dates of service through December 31, 2024. 
• Covid-19 testing services performed by a laboratory on and after January 1, 2025, will be subject to the allowable ordering providers under Medicaid laboratory policy, unless the PREP Act is further amended.

For full details on MDHHS notice 2419-Lab, go to michigan.gov. If you have any questions, contact your Blue Cross Complete provider account executive or the Blue Cross Complete Provider Inquiry at 1-888-312-5713.